Vanderbilt Center for Antibody Therapeutics (VCAT) Archive — Page 3 of 13

March 30, 2023

Crowe, Harris, Young elected as new AIMBE fellows

Vanderbilt’s James Crowe Jr., MD, Paul Harris, PhD, and Jamey Young, PhD, have been elected to the 2023 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).

By Mia Garchitorena-Scancarelli
Six people sit onstage in armchairs during the Research!America Advocacy Awards ’23 program, with a large “RESEARCH!AMERICA ADVOCACY AWARDS 23” screen behind them. One person holds a microphone and papers while the others sit listening.
March 23, 2023

Crowe’s research honored

Vanderbilt’s James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.

By Vanderbilt Health News
Illustration of red and pink Y-shaped antibodies surrounding blue spiky virus particles against a dark blue background.
March 16, 2023

Scientists resurrect a ‘dead’ antibody to study protein

Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.

By Bill Snyder
Graphic with a light gray speech bubble on a blue background, turquoise quotation marks, and the words “in the news.”
January 6, 2023

VUMC in the news, Jan. 10, 2023

Graphic with a light gray speech bubble on a blue background, turquoise quotation marks, and the words “in the news.”
December 9, 2022

VUMC in the news, Dec. 13, 2022

Laboratory sample tube and pipette on a colorful microarray-patterned surface.
November 17, 2022

Several from VUMC among most highly cited researchers

Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

By Bill Snyder